About: Myopericarditis following smallpox vaccination

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Myopericarditis following smallpox vaccination Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2004

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2004 (uk) im Oktober 2004 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 2004 (ast) scientific article published on 01 October 2004 (en)
publication date	wds:Q80596980-7780DDAD-515C-43F0-AFF8-AFEEF9FBEF22
publication date	2004-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q80596980-D0E2E512-FB19-427F-A6BF-3B69101BB04B
language of work or name	English
author name string	wds:Q80596980-0B740BE1-007E-4F60-8CA6-BDCF7237B936 wds:Q80596980-22404377-E684-4F97-B71D-1EF7E66893EB wds:Q80596980-264320D6-90E4-4ACA-9380-2C63C3F8C021 wds:Q80596980-2C984366-4BB1-466A-9F8A-ECF1B8864D88 wds:Q80596980-73AB3843-DC53-431C-9A57-4164E33E7E5A wds:Q80596980-954AB10B-2302-41A1-A813-DD4D03625D57 wds:Q80596980-C0B080CD-7A18-4832-B123-9D300A89544A wds:Q80596980-D32A5BCA-DCE0-43CF-B28B-C6E64495B540 wds:Q80596980-E4AC3AC3-2BD3-4A9A-8186-A8DB30A5AD0E wds:Q80596980-E67F3816-0129-4F28-BEF3-6DFE7E67074E wds:Q80596980-EEC21732-F1DC-4A54-B4AA-0E65688262F9
author name string	John D Grabenstein Robert E Eckart Timothy S Wells James R Riddle J Edwin Atwood Renata J M Engler Limone C Collins David N Tornberg Mark K Arness Sharon L Ludwig Suzanne S Love
rdfs:label	Myopericarditis following smallpox vaccination (en) Myopericarditis following smallpox vaccination (nl)
skos:prefLabel	Myopericarditis following smallpox vaccination (en) Myopericarditis following smallpox vaccination (nl)
name	Myopericarditis following smallpox vaccination (en) Myopericarditis following smallpox vaccination (nl)
title	wds:Q80596980-DEFE5B2E-2BB4-48AC-8289-50F82F83FDB4
title	Myopericarditis following smallpox vaccination (en)
page(s)	wds:Q80596980-8AA0A8A1-B334-4353-87A2-5444C34CB230
page(s)	642-651
instance of	wds:Q80596980-D11A1147-9177-4907-ABFE-CDEC650A932D
instance of	scholarly article
main subject	wds:Q80596980-C3BAA048-3ADF-4B48-BFDA-91964DECF15E
main subject	smallpox
PubMed ID	wds:Q80596980-C283429B-BC54-41BE-AE35-4C4A490B8F4B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15383408
PubMed ID	15383408
published in	wds:Q80596980-2C056990-F235-4334-AEE0-5FF1A4A5A1FC
published in	American Journal of Epidemiology
issue	wds:Q80596980-8679B815-4FE7-4C4C-A48A-36DDCEE0080B
volume	wds:Q80596980-CE88243A-640D-4F3C-818A-10664330AB14
issue	7
volume	160
DOI	wds:Q80596980-B95F056A-E311-427E-B886-D31338668546
DOI	http://dx.doi.org/10.1093/AJE/KWH269
DOI	10.1093/AJE/KWH269
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80596980
is cites work of	Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals Adventitious agents and smallpox vaccine in strategic national stockpile Smallpox vaccine and its stockpile in 2005. LC16m8: an attenuated smallpox vaccine Smallpox vaccination and ischemic coronary events in healthy adults A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects US military service members vaccinated against smallpox in 2003 and 2004 experience a slightly higher risk of hospitalization postvaccination Myocarditis Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected mice Frequency of adverse events after vaccination with different vaccinia strains Vaccines for preventing smallpox A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE. The Future of Smallpox Vaccination: is MVA the key? Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3. A prospective study of the incidence of myocarditis/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination Vaccinia virus A35R inhibits MHC class II antigen presentation Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II. Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial Smallpox ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis. UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV. Personalized vaccines: the emerging field of vaccinomics Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model Cardiac safety of Modified Vaccinia Ankara for vaccination against smallpox in a young, healthy study population Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial. Application of pharmacogenomics to vaccines Defending against smallpox: a focus on vaccines Acute perimyocarditis mimicking transmural myocardial infarction Raccoonpoxvirus safety in immunocompromised and pregnant mouse models Non-specific "non-effects" of vaccination A systematic review of validated methods to capture myopericarditis using administrative or claims data Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013. Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer The ghost of pandemics past U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007. Vaccination and risk of lone atrial fibrillation in the active component United States military Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System Cytokine production associated with smallpox vaccine responses

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software